Dosidal · Switzerland
Rybelsus N, Tabletten
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:69865 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 69865 atc: A10BJ06 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2025-11-28 term: zugelassen valid_until: 2030-11-27 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: A10BJ06 authorisation_number: 69865 form: TAB holder: Novo Nordisk Pharma AG holder_partner_nr: 1000306 it_number: 07.06.2. name: Rybelsus N, Tabletten state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53E0reZ-MnmVFu4QArcNT4vStFUEv4Y5UpfoEHze9CeOsHl5eeHkkzfP7a-fV9Jj0DmvXuM2jZSw0bo1SHMXSe7QVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |